Skip to main content
DAEWOONG CO.,LTD logo

DAEWOONG CO.,LTD — Investor Relations & Filings

Ticker · 003090 ISIN · KR7003090008 KO Manufacturing
Open in API
Filings indexed 309 across all filing types
Latest filing 2026-03-05 Regulatory Filings
Country KR South Korea
Listing KO 003090

About DAEWOONG CO.,LTD

https://www.daewoong.co.kr

Daewoong Co., Ltd. is a holding company operating primarily in the biotechnology and healthcare sectors. Its core business, conducted through subsidiaries like Daewoong Pharmaceutical, involves the research, development, manufacturing, and commercialization of a broad range of pharmaceutical products. The company's portfolio includes prescription drugs, over-the-counter (OTC) medications, quasi-drugs, and active pharmaceutical ingredients (APIs). Daewoong focuses on developing innovative drugs, with established expertise in gastrointestinal and endocrine therapeutic areas. A key product in its global portfolio is Nabota, an FDA-approved botulinum toxin. The company emphasizes continuous R&D and engages in open collaboration to develop new healthcare solutions.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(자회사의 주요경영사항)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Daewoong regarding the approval of a Phase 3 clinical trial plan (IND) for their drug 'Envlo' by the Korean Ministry of Food and Drug Safety. This is a standard corporate disclosure of material information regarding business operations and R&D progress. Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2026-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Daewoong Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as director activities and financial statements. This type of document is standard for proxy solicitation and shareholder meeting notification, which falls under the 'Proxy Solicitation & Information Statement' category.
2026-02-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Solicitation of Proxy' (의결권대리행사권유참고서류) issued by Daewoong Co., Ltd. for its 66th Annual General Meeting. It contains information regarding the meeting date, agenda, proxy solicitation details, and includes financial statements (balance sheet, income statement, etc.) as part of the reference materials for shareholders. This type of document is specifically categorized as a Proxy Solicitation & Information Statement.
2026-02-26 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Daewoong. It outlines the date, location, and agenda items (such as financial statement reporting, director/auditor appointments, and dividend proposals). This document serves as the official notification to shareholders regarding the upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement as it provides the necessary information for shareholders to exercise their voting rights.
2026-02-25 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Daewoong regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2026-02-25 Korean
현금ㆍ현물배당결정(자회사의 주요경영사항)
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Daewoong regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the upcoming general meeting of shareholders. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2026-02-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.